当前位置: 首页 >> 检索结果
521. Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis.
作者: S M A Fontenelle.;C Kayser.;M L C Pucinelli.;L E C Andrade.
来源: Rheumatology (Oxford). 2008年47卷1期80-3页
The recently developed cold stimulus fingertip lacticemy test (CS-FTL) provides biochemical assessment of peripheral perfusion in patients with Raynaud's phenomenon (RP). We evaluated how the CS-FTL test can assess the acute effect of nifedipine in microvascular dynamics on primary RP and RP secondary to SSc.
522. Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis.
To study prospectively the daily practice effectiveness of a step-down early rheumatoid arthritis (RA) treatment strategy.
523. The role of HLA-DRB1 shared epitope alleles in predicting short-term response to leflunomide in rheumatoid arthritis.
作者: G Saruhan-Direskeneli.;M Inanc.;I Fresko.;N Akkoc.;E Dalkilic.;E Erken.;Y Karaaslan.;G Kinikli.;F Oksel.;S Pay.;E Yucel.;S P Yentür.;J Duymaz-Tozkir.;V Yilmaz.;N Inanc.;H Yazici.;M Konice.;H Direskeneli.
来源: Rheumatology (Oxford). 2007年46卷12期1842-4页
To investigate the role of shared epitope (SE) alleles in the short-term clinical response to leflunomide for the treatment of active RA.
524. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women--a population-based, randomized, double-blind, placebo-controlled trial.
作者: H Smith.;F Anderson.;H Raphael.;P Maslin.;S Crozier.;C Cooper.
来源: Rheumatology (Oxford). 2007年46卷12期1852-7页
Low trauma fractures in older people incur enormous physical, social and economic costs. Previous research indicates that an annual intramuscular injection of vitamin D may reduce fracture rates in this group. This strategy requires validation in a population setting.
525. Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation.
作者: C E Vergunst.;D M Gerlag.;H Dinant.;L Schulz.;M Vinkenoog.;T J M Smeets.;M E Sanders.;K A Reedquist.;P P Tak.
来源: Rheumatology (Oxford). 2007年46卷12期1773-8页
All complement pathways lead to the formation of C5a, which is believed to contribute to the influx and activation of C5a-receptor (C5aR) bearing cells into the joints of patients with rheumatoid arthritis (RA). Studies in animal models of RA have suggested therapeutic potential of C5aR blockade. In this study, we examined the effects of the C5aR blockade on synovial inflammation in RA patients.
526. Arthritis patients show long-term benefits from 3 weeks intensive exercise training directly following hospital discharge.
作者: Y Bulthuis.;K W Drossaers-Bakker.;E Taal.;J Rasker.;J Oostveen.;P van't Pad Bosch.;F Oosterveld.;M van de Laar.
来源: Rheumatology (Oxford). 2007年46卷11期1712-7页
To examine the efficacy of short-term intensive exercise training (IET) directly following hospital discharge.
527. An economic evaluation of three physiotherapy treatments for non-specific neck disorders alongside a randomized trial.
作者: M Lewis.;M James.;E Stokes.;J Hill.;J Sim.;E Hay.;K Dziedzic.
来源: Rheumatology (Oxford). 2007年46卷11期1701-8页
Cost-effectiveness and cost-utility analyses were conducted to compare advice and exercise plus manual therapy (MT) and advice and exercise plus pulsed shortwave diathermy (PSWD) with advice and exercise alone (A&E) in the treatment of non-specific neck disorders by experienced physiotherapists.
528. Patient education in rheumatoid arthritis: the effectiveness of the ARC booklet and the mind map.
作者: D Walker.;A Adebajo.;P Heslop.;J Hill.;J Firth.;P Bishop.;P S Helliwell.
来源: Rheumatology (Oxford). 2007年46卷10期1593-6页
To determine the effectiveness of a pictorial 'mind map' together with the Arthritis Research Campaign (ARC) booklet for imparting knowledge to participants with rheumatoid arthritis (RA). Also, we wished to relate this to their reading ability.
529. Randomized trial of two physiotherapy interventions for primary care back and neck pain patients: cost effectiveness analysis.
作者: A Manca.;J C Dumville.;D J Torgerson.;J A Klaber Moffett.;M P Mooney.;D A Jackson.;S Eaton.
来源: Rheumatology (Oxford). 2007年46卷9期1495-501页
To assess the cost-effectiveness of a brief physiotherapy pain management approach using cognitive-behavioural principles (Solution-Finding Approach) when compared with a commonly used traditional method of physical therapy (McKenzie Approach).
530. Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial.
作者: G A Ferreira.;T P Navarro.;R W Telles.;L E C Andrade.;E I Sato.
来源: Rheumatology (Oxford). 2007年46卷10期1560-5页
Patients with systemic lupus erythematosus (SLE) have recognized reduction in endothelium-dependent vasodilation. Evidence demonstrates that statins are able to improve endothelial function independently on their hypolipemic action.
531. Cost-effectiveness of Spa treatment for fibromyalgia: general health improvement is not for free.
作者: T R Zijlstra.;L M A Braakman-Jansen.;E Taal.;J J Rasker.;M A F J van de Laar.
来源: Rheumatology (Oxford). 2007年46卷9期1454-9页
To estimate the cost-effectiveness of an adjuvant treatment course of spa treatment compared with usual care only in patients with fibromyalgia syndrome (FM).
532. Short-term outcome of painful bone marrow oedema of the knee following oral treatment with iloprost or tramadol: results of an exploratory phase II study of 41 patients.
作者: M E Mayerhoefer.;J Kramer.;M J Breitenseher.;C Norden.;A Vakil-Adli.;S Hofmann.;R Meizer.;H Siedentop.;F Landsiedl.;N Aigner.
来源: Rheumatology (Oxford). 2007年46卷9期1460-5页
To compare the therapeutic effects of oral iloprost and tramadol on the outcome of bone marrow oedema (BME) of the knee by MR imaging and clinical assessment.
533. Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-alpha antibody infliximab.
作者: X Baraliakos.;J Listing.;J Brandt.;H Haibel.;M Rudwaleit.;J Sieper.;J Braun.
来源: Rheumatology (Oxford). 2007年46卷9期1450-3页
Anti-tumour necrosis factor therapy with infliximab has been shown to improve signs and symptoms of patients with active ankylosing spondylitis (AS). The objective of this article was to study the effect of infliximab on structural changes in AS over 4 yrs.
534. Severe knee osteoarthritis: a randomized controlled trial of acupuncture, physiotherapy (supervised exercise) and standard management for patients awaiting knee replacement.
To evaluate the effects of standardized western acupuncture and physiotherapy on pain and functional ability in patients with severe osteoarthritic knee pain awaiting knee arthroplasty.
535. Do baseline characteristics predict response to treatment for low back pain? Secondary analysis of the UK BEAM dataset [ISRCTN32683578].
To identify characteristics of randomized controlled trial participants which predict greater benefits from physical treatments for low back pain. If successful, this would allow more appropriate selection of patients for different treatments.
536. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
作者: C Metzler.;N Miehle.;K Manger.;C Iking-Konert.;K de Groot.;B Hellmich.;W L Gross.;E Reinhold-Keller.; .
来源: Rheumatology (Oxford). 2007年46卷7期1087-91页
Results from open-label trials suggest that methotrexate (MTX) and leflunomide (LEF) are effective for maintenance of remission in Wegener's granulomatosis (WG), but data from randomized controlled clinical trails are not yet available.
537. Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice.
作者: S Bombardieri.;A A Ruiz.;P Fardellone.;P Geusens.;F McKenna.;K Unnebrink.;U Oezer.;S Kary.;H Kupper.;G R Burmester.; .
来源: Rheumatology (Oxford). 2007年46卷7期1191-9页
To evaluate the effectiveness and safety of adalimumab in patients with rheumatoid arthritis (RA) who previously discontinued tumour necrosis factor (TNF) antagonists for any reason in clinical practice.
538. Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritis.
作者: C A E Walsh.;P Minnock.;C Slattery.;N Kennedy.;F Pang.;D J Veale.;B Bresnihan.;O FitzGerald.
来源: Rheumatology (Oxford). 2007年46卷7期1148-52页
To evaluate the quality of life and economic impact of switching therapy from infliximab to adalimumab in patients with rheumatoid arthritis (RA).
539. Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout.
作者: R E Willburger.;E Mysler.;J Derbot.;T Jung.;H Thurston.;A Kreiss.;S Litschig.;G Krammer.;G A Tate.
来源: Rheumatology (Oxford). 2007年46卷7期1126-32页
To demonstrate non-inferiority of lumiracoxib 400 mg once daily (o.d.) compared with indomethacin 50 mg three times daily (t.i.d.) in the treatment of acute gout, and to compare the safety and tolerability of these treatments.
540. A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases.
作者: Michael H Weisman.;Harold E Paulus.;Francis X Burch.;Alan J Kivitz.;Joshua Fierer.;Meleana Dunn.;David R Kerr.;Wayne Tsuji.;Scott W Baumgartner.
来源: Rheumatology (Oxford). 2007年46卷7期1122-5页
To evaluate the safety of etanercept in patients with rheumatoid arthritis (RA) and concomitant comorbidities.
|